INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2012

Water-dispersible hesperetin was rapidly absorbed and improved peripheral vasodilatation in women.

In a human trial involving women with cold sensitivity, an oral dose of 150 mg micronized hesperetin was rapidly absorbed, reaching a maximum concentration of 10.2 ± 1.2 μM within 1 hour. This single dose proved effective at enhancing peripheral vasodilatation. Complementary cell experiments showed its conjugated metabolite promoted endothelial nitric oxide production through inhibition of NADPH oxidase activity.

Study type
Clinical trial with in vitro study
Who was studied
Adult women with cold sensitivity
What was measured
Bioavailability and peripheral vasodilatation

THE PAPER

Bioavailability of orally administered water-dispersible hesperetin and its effect on peripheral vasodilatation in human subjects: implication of endothelial functions of plasma conjugated metabolites.

Takumi H, Nakamura H, Simizu T, Harada R, Kometani T, Nadamoto T, Mukai R, Murota K, Kawai Y, Terao J. Food Funct, 2012.

PubMed 22307524 ↗DOI 10.1039/c2fo10224b ↗

Heart & arteriesNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.